CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
12 years old with moderate to severe asthma....
Phase 2
Budapest, Hungary and 22 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Budapest, Hungary and 252 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...
Phase 3
Budapest, Hungary and 51 other locations
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Szazhalombatta, Hungary and 151 other locations
This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...
Phase 2
Százhalombatta, Hungary and 69 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Budapest, Hungary and 73 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Budapest, Hungary and 382 other locations
This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...
Phase 2
Gödöllő, Hungary and 159 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Budapest, Hungary and 371 other locations
phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma...
Phase 2
Budapest, Hungary and 203 other locations
Clinical trials
Research sites
Resources
Legal